BEST1
Basic information
Region (hg38): 11:61950063-61965515
Previous symbols: [ "VMD2" ]
Links
Phenotypes
GenCC
Source: 
- autosomal dominant vitreoretinochoroidopathy (Strong), mode of inheritance: AD
- vitelliform macular dystrophy 2 (Definitive), mode of inheritance: AD
- autosomal dominant vitreoretinochoroidopathy (Moderate), mode of inheritance: AD
- autosomal recessive bestrophinopathy (Definitive), mode of inheritance: AR
- retinitis pigmentosa (Supportive), mode of inheritance: AD
- autosomal dominant vitreoretinochoroidopathy (Supportive), mode of inheritance: AD
- vitelliform macular dystrophy 2 (Supportive), mode of inheritance: AD
- nanophthalmia (Supportive), mode of inheritance: AD
- adult-onset foveomacular vitelliform dystrophy (Supportive), mode of inheritance: AD
- autosomal recessive bestrophinopathy (Supportive), mode of inheritance: AR
- MRCS syndrome (Supportive), mode of inheritance: AD
- autosomal recessive bestrophinopathy (Definitive), mode of inheritance: AR
- vitelliform macular dystrophy 2 (Definitive), mode of inheritance: AD
- autosomal recessive bestrophinopathy (Strong), mode of inheritance: AR
- vitelliform macular dystrophy 2 (Strong), mode of inheritance: AD
- autosomal dominant vitreoretinochoroidopathy (Strong), mode of inheritance: AD
- retinitis pigmentosa 50 (Strong), mode of inheritance: AD
- inherited retinal dystrophy (Definitive), mode of inheritance: AD
- autosomal dominant vitreoretinochoroidopathy (Definitive), mode of inheritance: AD
- retinitis pigmentosa (Definitive), mode of inheritance: AR
- retinitis pigmentosa 50 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Vitreoretinochoroidopathy | AD | Ophthalmologic; Pharmacogenomic | Findings such as glaucoma and retinal detachment have been described, and surveillance and early treatment (eg, direct laser photocoagulation and anti-vascular endothelial growth factors for choroidal neovascularization and hemorrhage), as well as preventive measures, may be beneficial; Agents that may contribute to glaucoma, as well as smoking, should be avoided | Ophthalmologic | 13546939; 838599; 7065944; 6689931; 8431155; 9662395; 10453731; 10331951; 10854112; 10737974; 11585313; 12543751; 15452077; 16458719; 16678511; 17698758; 17591911; 18179881; 18611979; 19853238; 20057903; 20301346; 20375334; 20847757; 21192766; 21320969; 22422030; 22584882; 22633354; 23290749; 23572118; 23765342; 23823511; 24345323 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_provided (748 variants)
- Retinal_dystrophy (185 variants)
- Vitelliform_macular_dystrophy_2 (127 variants)
- Autosomal_recessive_bestrophinopathy (55 variants)
- Autosomal_dominant_vitreoretinochoroidopathy (52 variants)
- Inborn_genetic_diseases (44 variants)
- BEST1-related_disorder (38 variants)
- Retinitis_pigmentosa (35 variants)
- Retinitis_pigmentosa_50 (19 variants)
- not_specified (9 variants)
- Retinitis_Pigmentosa,_Recessive (7 variants)
- Iron_Overload (7 variants)
- BEST1-related_dominant_retinopathy (6 variants)
- Stargardt_disease (5 variants)
- Macular_dystrophy (5 variants)
- Isolated_macular_dystrophy (2 variants)
- Vitelliform_macular_dystrophy_1 (1 variants)
- Microcornea,_rod-cone_dystrophy,_cataract,_and_posterior_staphyloma_2 (1 variants)
- See_cases (1 variants)
- Rod-cone_dystrophy (1 variants)
- Cone-rod_dystrophy_6 (1 variants)
- maculopathy (1 variants)
- Severe_early-childhood-onset_retinal_dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BEST1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004183.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 13 | 104 | 120 | |||
| missense | 97 | 166 | 262 | 16 | 544 | |
| nonsense | 14 | 27 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 30 | 41 | ||||
| splice donor/acceptor (+/-2bp) | 21 | |||||
| Total | 148 | 193 | 286 | 120 | 7 | 
Highest pathogenic variant AF is 0.0002857187
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| BEST1 | protein_coding | protein_coding | ENST00000449131 | 8 | 15695 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 1.82e-12 | 0.0314 | 125713 | 0 | 35 | 125748 | 0.000139 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.617 | 289 | 320 | 0.903 | 0.0000178 | 3952 | 
| Missense in Polyphen | 74 | 103.35 | 0.71605 | 1255 | ||
| Synonymous | 0.804 | 122 | 134 | 0.912 | 0.00000794 | 1181 | 
| Loss of Function | -0.0233 | 18 | 17.9 | 1.01 | 8.53e-7 | 181 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000235 | 0.000235 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.000381 | 0.000381 | 
| Finnish | 0.0000462 | 0.0000462 | 
| European (Non-Finnish) | 0.000150 | 0.000149 | 
| Middle Eastern | 0.000381 | 0.000381 | 
| South Asian | 0.0000344 | 0.0000327 | 
| Other | 0.000326 | 0.000326 | 
dbNSFP
Source: 
- Function
- FUNCTION: Forms calcium-sensitive chloride channels. Highly permeable to bicarbonate. {ECO:0000269|PubMed:11904445, ECO:0000269|PubMed:12907679, ECO:0000269|PubMed:18400985}.;
- Disease
- DISEASE: Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]: An autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss. {ECO:0000269|PubMed:10331951, ECO:0000269|PubMed:10394929, ECO:0000269|PubMed:10453731, ECO:0000269|PubMed:10682987, ECO:0000269|PubMed:10798642, ECO:0000269|PubMed:11241846, ECO:0000269|PubMed:11449320, ECO:0000269|PubMed:12187431, ECO:0000269|PubMed:12324875, ECO:0000269|PubMed:13129869, ECO:0000269|PubMed:14517959, ECO:0000269|PubMed:15176385, ECO:0000269|PubMed:18400985, ECO:0000269|PubMed:18766995, ECO:0000269|PubMed:19357557, ECO:0000269|PubMed:21330666, ECO:0000269|PubMed:9662395, ECO:0000269|PubMed:9700209}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 50 (RP50) [MIM:613194]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:19853238}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]: A retinopathy characterized by loss of central vision, an absent electro-oculogram light rise, and electroretinogram anomalies. {ECO:0000269|PubMed:18179881, ECO:0000269|PubMed:19853238, ECO:0000269|PubMed:21330666, ECO:0000269|PubMed:26200502, ECO:0000269|PubMed:26720466}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vitreoretinochoroidopathy, autosomal dominant (ADVIRC) [MIM:193220]: A disorder characterized by vitreoretinochoroidal dystrophy. The clinical presentation is variable. VRCP may be associated with cataract, nanophthalmos, microcornea, shallow anterior chamber, and glaucoma. {ECO:0000269|PubMed:15452077}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Stimuli-sensing channels;Ion channel transport;Transport of small molecules (Consensus) 
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.0103
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.66
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.827
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Best1
- Phenotype
- cellular phenotype; pigmentation phenotype; reproductive system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- chloride transport;visual perception;bicarbonate transport;transepithelial chloride transport;ion transmembrane transport;detection of light stimulus involved in visual perception;regulation of calcium ion transport;chloride transmembrane transport
- Cellular component
- cytosol;plasma membrane;membrane;integral component of membrane;basolateral plasma membrane;chloride channel complex
- Molecular function
- intracellular calcium activated chloride channel activity;chloride channel activity;bicarbonate transmembrane transporter activity;identical protein binding